Antibacterial agent 166
Antibacterial agent 166 (Compound 19q), a derivative of Nitisinone (HY-B0607), is a selective and orally active Fusobacterium nucleatum inhibitor with a MIC50 of 1 μg/mL. Antibacterial agent 166 effectively attenuates the migratory ability of MC-38 cells induced by Fusobacterium nucleatum. Antibacterial agent 166 is a promising anti-F. nucleatum lead compound and can be used for colorectal cancer (CRC) research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C11H8ClN3O4
- 分子量:281.65
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
Antibacterial agent 166 (Compound 19q) (1-4 μg/mL, 0-72 h) inhibits the growth and biofilm formation of Fusobacterium nucleatum in a dose dependent manner[1].
Antibacterial agent 166 (1-4 μg/mL, 4-48 h) inhibits the growth of Fusobacterium nucleatum by downregulating the expression of NTR[1].
Antibacterial agent 166 (1-4 μg/mL, 48 h) downregulates the expression of the tnaA gene in the late-log-phase in a dose-dependent manner[1].
Antibacterial agent 166 (2-4 μg/mL, 48 h) possesses stronger migratory inhibition potency against MC-38 under the stimulation of Fusobacterium nucleatum[1].
Antibacterial agent 166 exhibits the most potent inhibitory activity against MC-38 cells, with an IC50 of 11 μM[1].
Antibacterial agent 166, exhibits moderate to weak antiproliferative activity two human normal cell lines with an IC50 of 16 μM, possess low cytotoxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
体内実験
Antibacterial agent 166 (20 mg/kg, p.o, single dose) can inhibit Fusobacterium nucleatum locally in the intestinal tract and has lower systemic toxicity[1].
Antibacterial agent 166 (1 mg/kg, Intravenous injection) half-life is approximately 0.068 h, the peak concentration Cmax and plasma clearance (CL) were 85 ng/mL and 36054 mL/h/mg[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
分子量 281.65
-
分子式 C11H8ClN3O4
-
SMILES
ClC1=CN=C(CNC(C2=CC=C([N+]([O-])=O)O2)=O)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)